Endometriosis now has its own fertility pathway in NICE guidance
The updated fertility guideline includes a brand-new section specifically for those with endometriosis who are struggling to conceive.
We produce useful and usable guidance for the NHS and wider health and care system.
Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
Latest from NICE
New life-extending treatment given the green light for people with rare form of bile duct cancer
A new targeted treatment for a rare and aggressive form of bile duct cancer has been recommended by NICE for routine use on the NHS in England, giving people more time with better quality of life.
New take at home drug recommended for people with chronic lymphocytic leukaemia
Our latest draft guidance recommends pirtobrutinib, a new take at home tablet, that could give patients greater choice and reduce the need for frequent hospital visits.
‘Trojan horse’ treatment recommended for people with multiple myeloma
Around 1,600 people a year in England with multiple myeloma are set to benefit from a new treatment option after we recommended belantamab mafodotin (also known as Blenrep and made by GSK).
Implementation and planning
Best practice resources for practitioners and commissioners.
Helping you define, improve and measure quality in health, public health and social care.
Resources and recommendations for adult and children’s social care, with example scenarios to help put them into practice.
Explore ways to plan, save money and make decisions on the best ways to use resources.
More ways we support you
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
The British National Formulary (BNF) provides information about the selection, prescribing, dispensing and administration of drugs.
With over 370 topics to choose from, clinical knowledge summaries (CKS) can provide quick answers to clinical questions.
Our patient decision aids (PDAs) include treatment options available, likely outcomes, benefits, harms and uncertainties.
